Clearside Biomedical 株価情報 (NASDAQ: CLSD)

最新ニュース Clearside Biomedical (NASDAQ:CLSD) 株価情報

CLEARSIDE BIOMEDICAL INC

Clearside Biomedical

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical Inc

News

Reported Earlier, McEwen Mining Starts Construction At Fox Complex's Stock Mine With Goal To Reduce Per-Ounce Costs And Raise Output In 2025

This collaboration aims to deliver highly sensitive, cost-effective, and decentralized MRD testing solutions that enable oncologists to monitor cancer recurrence and guide personalized treatment decisions using minimally invasive blood samples.

QGEN

Reported Earlier, Tracer Biotechnologies And QIAGEN Partner To Co-Develop Blood-Based MRD Assays For Solid Tumors On QIAcuity Digital PCR Platform

Reported Earlier, Grupo Aeroportuario del Pacífico Sees 2.6% Increase In May 2025 Passenger Traffic Compared To Prior Year

<ul>
<li>Total gross proceeds of up to $150.0 million before the end of 2026 if all Series B warrants and Series C warrants are exercised for cash</li>
<li>Xilio may elect to cancel unexercised Series B or Series C warrants proportionately to the amount of non-dilutive capital received, under certain circumstances</li>
<li>Financing co-led by new investors Coastlands Capital and Frazier Life Sciences and included participation from Gilead Sciences, Inc., Logos Capital, Samsara BioCapital and other new and existing investors</li>
</ul>

Reported Earlier, Xilio Therapeutics Closes $50M Public Offering, With Potential To Raise Up To $150M Through Warrant Exercises By 2026

FIBK

Reported Earlier, First Interstate BancSystem Announces $125M Public Offering Of Subordinated Notes With 7.625% Fixed Rate Through 2030

CYBR

Reported Earlier, CyberArk Software Announces Pricing of $1.1B 0.00% Convertible Notes Due 2030, Upsized From Initial $750M Offering

Reported Earlier, WEC Energy Group Upsizes Convertible Notes Offering To $775M, Pricing 3.375% Senior Notes Due 2028

The war of words between President Donald Trump and his former advisor, Tesla Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Elon Musk, reached new heights when the latter publicly backed a call to impeach the President and replace him with Vice President JD Vance.
What Happened: Amid the <a href="https://www.benzinga.com/news/politics/25/06/45800612/trump-says-musk-has-trump-derangement-syndrome-as-battle-over-bill-heats-up-had-a-great-relationship-dont-know-if-we-will-anymore">ongoing feud</a> between two of the world's most powerful individuals, right-wing commentator Ian Miles Cheong posted: "President vs Elon. Who wins? My money's on Elon. Trump should be impeached and JD Vance should replace him."
Musk replied with a "Yes" around 20 minutes later. Cheong's post was accompanied by a screenshot of a post Musk made earlier, alleging that Trump's name appears in the Epstein files.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">President vs Elon. Who wins? My money&#39;s on Elon. Trump should be impeached and JD Vance should replace him. <a href="https://t.co/r0D4Gkiz4v">pic.twitter.com/r0D4Gkiz4v</a>
&mdash; Ian Miles Cheong (@stillgray) <a href="https://twitter.com/stillgray/status/1930713852175331335?ref_src=twsrc%5Etfw">June 5, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: <a href="https://www.benzinga.com/news/movers-shakers/25/06/45807280/elon-musk-bleeds-34-billion-as-tesla-shares-tank-14-amid-spat-with-trump-how-the-billionaires-fortune-has-fared-so-far-in-2025">The fallout</a> between the two men was triggered by Musk's <a href="https://www.benzinga.com/news/25/05/45635854/elon-musk-disappointed-with-trumps-big-beautiful-bill-says-it-undermines-the-work-that-the-doge-team-is-doing">sharp criticism of Trump's "big, beautiful bill"</a>. The conflict escalated after Trump said he was "very surprised" and "very disappointed" in Musk's comments. Musk pushed back, claiming he had helped Trump win in 2024 and accused him of "ingratitude."
The <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45805173/musk-vs-trump-tesla-suffers-record-152b-one-day-crash-as-ceo-warns-tariffs-will-cause-a-recession">trading of insults continued</a>, with Musk posting: &#8220;Congress is spending America into bankruptcy!&#8221; and Trump stating, &#8220;I don&#8217;t mind Elon turning against me, but he should have done so months ago. This is one of the Greatest Bills ever presented to Congress.&#8221;
Trump and Musk also sparred over Musk's EV mandate, with the former alleging that the removal of the mandate had caused Musk to go "CRAZY."
Press secretary Karoline Leavitt reacted to the situation, saying: "This is an unfortunate episode from Elon, who is unhappy with the One Big Beautiful Bill because it does not include the policies he wanted."
Tesla lost a staggering $152 billion in market value on Thursday, marking a record single-day decline. Despite the drop, the electric vehicle maker still carries a consensus price target of $299.60, based on assessments from 26 analysts.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="1024" height="378" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06020135/image-79.png" alt="" class="wp-image-940697" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06020135/image-79.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06020135/image-79-300x111.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06020135/image-79-768x284.png 768w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Price Action: Tesla shares have dropped 24.50% so far this year. However, in Thursday's after-hours trading, the stock edged up 0.77% to close at $286.90, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
<figure class="wp-block-image aligncenter size-full is-resized"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="442" height="270" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06020148/image-80.png" alt="" class="wp-image-940698" style="width:436px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06020148/image-80.png 442w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06020148/image-80-300x183.png 300w" sizes="(max-width: 442px) 100vw, 442px" /></a></figure>
Benzinga&#8217;s Edge Stock Rankings point to Tesla's solid price momentum across short, medium, and long-term trends. More detailed performance insights can be <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">found here</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/movers-shakers/25/06/45807280/elon-musk-bleeds-34-billion-as-tesla-shares-tank-14-amid-spat-with-trump-how-the-billionaires-fortune-has-fared-so-far-in-2025">Elon Musk Loses $34 Billion As Tesla Sheds $153 Billion Amid Feud With Trump—Here&#8217;s How The Billionaire&#8217;s Fortune Has Fared So Far In 2025</a></li>
</ul>
Photo courtesy: Shutterstock

Politics

Markets

TSLA

Elon Musk Says 'Yes' To Impeaching Trump, Replacing Him With JD Vance Amid Fierce Back-And-Forth Over 'Big, Beautiful Bill'

Reported Earlier, CN To Issue C$500M In 3.500% Notes Due 2030 And C$500M In 4.200% Notes Due 2035, Closing Expected June 10, 2025

President&nbsp;Donald Trump&nbsp;has hinted at a possible reconciliation with&nbsp;Elon Musk&nbsp;following a public spat. The White House is reportedly working to de-escalate the situation.
What Happened: Trump, in an interview with&nbsp;<a href="https://www.politico.com/news/2025/06/05/trump-white-house-aides-signal-a-possible-detente-with-musk-00391502">Politico</a>&nbsp;on Thursday, appeared nonchalant about his recent social media clashes with Musk. The President&#8217;s aides have been urging him to tone down&nbsp;his public criticism of Musk&nbsp;to prevent further escalation. They have even scheduled a call with Musk to potentially resolve the conflict.
Despite the apparent tension, Trump seemed unfazed, stating, "Oh it's okay."
&#8220;It&#8217;s going very well, never done better.&#8221; He also mentioned his high favorability ratings, indicating a possible shift in his stance towards Musk.
The White House did not immediately respond to <a href="http://pro.benzinga.com">Benzinga&#8217;s</a> request for comment. 
The feud between the two influential figures centered around Trump&#8217;s &#8220;big beautiful bill,&#8221; a legislative proposal encompassing his presidential agenda. The exchanges became increasingly acrimonious, prompting aides and allies to intervene and Musk to show a willingness to mend fences.
Earlier on Thursday, Trump, at the behest of his aides, moderated his comments on social media, focusing on the bill&#8217;s passage through the Senate rather than the conflict with Musk. This change in tone was evident in one of Trump&#8217;s Truth Social posts.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="602" height="300" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06020016/image-78.png" alt="" class="wp-image-940694" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06020016/image-78.png 602w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06020016/image-78-300x150.png 300w" sizes="(max-width: 602px) 100vw, 602px" /></figure>
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/06/45800902/the-white-house-pushes-back-with-a-mythbuster-article-saying-people-wont-literally-die-from-their-tax-bill" target="_blank" rel="noreferrer noopener">The White House Pushes Back With A &#8216;Mythbuster&#8217; Article Saying People Won&#8217;t &#8216;Literally Die&#8217; From Their Tax Bill</a>
Why It Matters: This feud has strained the <a href="https://www.benzinga.com/news/politics/25/06/45800612/trump-says-musk-has-trump-derangement-syndrome-as-battle-over-bill-heats-up-had-a-great-relationship-dont-know-if-we-will-anymore">once close</a> relationship between Trump and Musk, who was instrumental in the Department of Government Efficiency during the early days of Trump&#8217;s administration.
The public spat between Trump and Musk has had significant repercussions. Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares plummeted by 14.26%, <a href="https://www.benzinga.com/news/movers-shakers/25/06/45807280/elon-musk-bleeds-34-billion-as-tesla-shares-tank-14-amid-spat-with-trump-how-the-billionaires-fortune-has-fared-so-far-in-2025">erasing $152 billion </a>in market capitalization, marking its largest single-day decline. This feud has not only affected Tesla&#8217;s stock but also Musk&#8217;s personal fortune.
 The potential truce could help mend their relationship and possibly stabilize Tesla&#8217;s stock.
Tesla stock plunged 14.26% on a single day and closed at $284.70 on Thursday. It recovered 0.77% during the after-hours trading, as per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/tech/25/06/45784639/jeff-bezos-let-customers-cancel-their-own-amazon-orders-and-it-paid-off-big-if-you-give-people-more-" target="_blank" rel="noreferrer noopener">Jeff Bezos Let Customers Cancel Their Own Amazon Orders And It Paid Off Big: &#8216;If You Give People More Control&#8230;Maybe They&#8217;ll Order More&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump Signals Truce With Elon Musk After Online Feud: 'It's Going Very Well, Never Done Better'

ADXN

Addex Therapeutics Reports Preclinical Results For GABAB PAM, Demonstrating Superior Efficacy And Tolerability In Chronic Cough Models

HIVE

HIVE Digital Technologies Surpasses 10 EH/s In May 2025 With 58% Monthly Hashrate Growth, On Track For 25 EH/s By Year-End

Focus remains on delivering market-leading solutions to SMEs across Ireland and the broader European market

Fiserv To Acquire Remaining 49.9% Stake In AIB Merchant Services, Accelerating Growth Across Ireland And The Broader European Market

Macro Economic Events

Econ #s

Economics

Germany Trade Balance For April 14.6B Vs. 20.2B Est.; 21.2B (Revised) Prior

Germany Industrial Production (MoM) For April -1.4% Vs. -0.9% Est.; 2.3% (Revised) Prior

U.K. Halifax House Price Index (YoY) For May 2.5% Vs. 3.2% Prior

U.K. Halifax House Price Index (MoM) For May -0.4% Vs. 0.4% Est.; 0.3% Prior

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, Japan Household Spending (MoM) For April -1.8% Vs. -0.8% Est.; 0.4% Prior

Reported Earlier, Japan Household Spending (YoY) For April -0.1% Vs. 1.5% Est.; 2.1% Prior

INDA

India Interest Rate Decision 5.50%	Vs. 5.75% Est.; 6.00% Prior

Press Releases

Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on Thursday, March 27, 2025

Clearside Biomedical's Lead Clinical Program CLS-AX in Wet AMD  and Suprachoroidal Delivery Platform Highlighted at the  2025 Wet AMD & Diabetic Eye Disease Summit

Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

Earnings

Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

Health Care

Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update

Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum

Comments

Clearside Biomedical

ニュース

最新ニュース Clearside Biomedical (NASDAQ:CLSD) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル